Fresh analysis indicates that people who discontinue popular weight-loss injections like Wegovy and Mounjaro may regain reduced body mass much more quickly than those who end conventional lifestyle plans.
Published data in a major health publication points out that while overweight people frequently drop about a fifth of their total mass while undergoing treatment, the weight comes back at an estimated rate of nearly a kilo each month upon discontinuation.
"People using these medications should be cognizant of the risk of quick rebound weight gain when the treatment concludes," warns researcher Dr. Susan Jebb.
That rate of recovery implies a return to pre-treatment mass within about a year and a half.
Comparing Treatments
The analysis, which examined dozens of trials involving thousands of participants, contrasted the outcomes of these new drugs with older methods.
Researchers emphasize that people who lose weight through lifestyle changes alone usually experience a more gradual weight regain—approximately 0.1 kg a month—once they finish.
Understanding the Quick Rebound
Experts believe the way of the jabs explains the accelerated rebound.
The injections imitate a natural hormone called GLP-1, which moderates hunger.
"Sustained high doses of the hormone levels several times higher than the body's typical production may cause the system to produce less of its endogenous GLP-1, and could reduce responsiveness to its effects," said Dr. Adam Collins, a nutrition specialist.
"Stopping of this GLP-1 'fix' leads to appetite is unsuppressed, making excessive eating much more probable."
A Lifelong Condition?
Health authorities advise the injections for people with weight-linked health risks, alongside prescribed lifestyle changes.
A number of clinicians contend that, given the high risk of weight regain, the therapy is often ongoing.
This view is reinforced by drug manufacturers, who say that the findings "underscore the persistent nature of obesity," comparing it to managing diseases like high blood pressure.
User Experiences
Users who have discontinued the jabs explain a powerful return of cravings.
"It was like a trigger flipping and you become extremely hungry," described one woman.
This challenge is worsened if patients have not established permanent dietary or behavioural modifications during treatment.
Widespread Use
Figures suggest that millions of adults in the UK have tried these injections in the last 12 months, with demand being substantial.
- Use is higher among women compared to males.
- The middle-aged age group shows the highest usage rates.
- A large proportion access the drugs through private healthcare rather than the NHS.
In conclusion, researchers emphasize that while these medications are powerful agents for shedding pounds, they are not a magic solution and lasting health benefits hinges on combined behavioural changes.
